drugset / Trial / NCT01521819

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

NCT01521819

Unknown 12 enrolled Oraya Therapeutics, Inc.
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot, single-center, interventional clinical trial in which subjects will receive 16 Gy of IRay treatment and Lucentis, followed by Lucentis treatment as needed.

Timeline

Start
2012-08
Primary completion
2013-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Background Ranibizumab Monoclonal antibody Intravitreal